Skip to main content
Fig. 1 | Allergy, Asthma & Clinical Immunology

Fig. 1

From: Effective treatment of a child with adenoidal hypertrophy and severe asthma by omalizumab: a case report

Fig. 1

Effect of omalizumab on the adenoidal sizes.  A Before treatment. Size shown is rated grade III; B After 4 weeks of treatment. The size is rated grade II; C After 12 weeks of treatment. The size is now rated grade I; D The size was maintained to grade I after treatment ended for 6.5 months. Red arrow: Vomer; Blue arrow: Adenoid; Yellow arrow: Pharyngeal orifice of eustachian tube

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us